The Women's Health Research Unit at OHSU

01/29/2024

New publication alert!👩‍🔬🔬📄

The results highlighted in the Business Wire's publication "Bayer's elinzanetant meets all primary and key secondary endpoints in pivotal OASIS 1 and 2 Phase 3 studies" bring us one step closer to providing effective solutions for folks experiencing menopausal symptoms.

Read more- https://urldefense.com/v3/__https:/www.businesswire.com/news/home/20240108102481/en/Bayer**Bs-elinzanetant-meets-all-primary-and-key-secondary-endpoints-in-pivotal-OASIS-1-and-2-Phase-III-studies__;4oCZ!!Mi0JBg!NNDWH_Yvzf1Z9b9VpUR05dovdZ9qI5x2dJohmdvn-yxi52RfmpTksa1Ql3UD6Y-VVC5Fxrdx9sPvj_6AZ3BkqpaiWw$

11/30/2023

Study using TikTok finds teens lack understanding of menstrual health🧑‍⚕️🩸

OHSU News recently published a story highlighting the importance of standardized menstrual health education for adolescents. Learn more about the study from our OHSU physician and researcher Maureen Baldwin, M.D., M.P.H.

Read more- https://news.ohsu.edu/2023/11/17/study-using-tiktok-finds-teens-lack-understanding-of-menstrual-health

11/03/2023

Comunidad, todos están invitados a unirse a nuestra Unidad de Investigación de Salud de la Mujer en OHSU en nuestra proxima mesa informativa. Se llevará a cabo mañana 4 de noviembre de 9:00 a.m. a 3:00 p.m. ¡Es un evento gratuito de feria de salud organizado por Telemundo Portland ! Estaremos ubicados en el tejaban #40.

Community, you are all invited to join our The Women's Health Research Unit at OHSU in our upcoming tabling event. It will be held tomorrow, November 4th from 9:00AM to 3:00PM. It is a free health fair event being hosted by Telemundo Portland! We will be located in booth #40.

11/03/2023

On Monday, October 30th our Women's Health and Pregnancy Research teams volunteered at the Oregon Food Bank! All 10 of us had an amazing time. We were able to assort and help unpack 6 pallets with other members of the community. This equates to 2,400 pounds of tea total 🥳!

The tea will be distributed to food banks across our state🫖🚛!

Thank you Oregon Food Bank for having us! We look forward to volunteering with you in the future!

07/24/2023

Contraceptive Announcement!

✨First FDA-Approved Over-the-Counter Daily B.C. Pill ✨

Our OB/GYN Department Women's Health Research Unit and those individuals who volunteered to participate in the research were an integral part of the approval process. They were part of a sponsored research study that provided critical research needed for this application (over the counter approval requires some different information than an initial drug approval.

💊The pill won’t likely be available until early 2024 but it will be the most effective contraceptive method available to consumers without a prescription! 💊

🧐For more information, check out Perrigo's announcement- https://investor.perrigo.com/2023-07-13-Perrigo-Announces-U-S-FDA-Approval-for-Opill-R-OTC-Daily-Oral-Contraceptive

05/26/2023

🌟 Highlighting our Providers🌟
Alyssa Colwill, M.D., assistant professor in the OHSU School of Medicine and Bethany Samuelson Bannow, M.D., assistant professor within the OHSU division of hematology/medical oncology, are investigating the use of alternative menstrual products.

🩸To read the full article, visit the following link:https://news.ohsu.edu/file/menstrual-technology-main-crop?action=
🩸Learn more about our heavy menstrual bleeding studies:https://ohsu.edu/womens-health/currently-enrolling-studies

Source: OHSU Now -https://news.ohsu.edu/file/menstrual-technology-main-crop?action=

04/19/2023

✨ Providers highlight!✨

Andrew Chon, M.D. and Raphael Sun, M.D. are surgeons in complex fetal care at OHSU!

Learn about the surgery they did for twin-to-twin transfusion syndrome- https://news.ohsu.edu/2023/03/30/twins-facing-life-threatening-condition-go-home-healthy-thanks-to-ohsu-fetal-surgery-team

Source: Lisa McMahan, OHSU News

04/07/2023

✨Provider Highlight✨

Check out Gynecologic Oncologist Dr. Amanda Brugel's interview with OHSU. Learn about the research Dr.. Brugel is doing to eliminate one of the leading causes of death worldwide among women: cervical cancer.

Source: OHSU Foundation https://ohsufoundation.org/stories/four-questions-amanda-bruegl/?utm_source=ohsu&utm_medium=social&utm_campaign=ohsu-now

03/10/2023

✨Check out this new study!✨

Have you been diagnosed with a complicated vaginal yeast infection? We have a study you may be eligible to participate in.

We are studying how well a new drug works to treat complicated vaginal yeast infections. We are specifically recruiting people who have not had success with fluconazole therapy.

Participants will be compensated up to $698.25 ($99.75 a visit) for out of pocket expenses such as travel and parking.

If you are interested, please contact us via our confidential recruitment line at 503-494-3666 or email us at whru@ohsu.edu!

Principal Investigator: Catherine Leclair, MD
eIRB #: 00024702

01/26/2023

🩸Do you have heavy periods? Join a research study to help diagnose heavy periods!🩸

🩸In order to diagnose heavy periods, healthcare providers typically depend on information like how often disposable pads or tampons are changed.
🩸Many people prefer to use menstrual cups and/or period underwear, so we need information on how frequent individuals with heavy periods empty cups or saturate underwear.
🩸 This study does not require medications. Participants must be comfortable using different period products (i.e menstrual cup or period underwear)

To find out more information and to learn if you are qualified to participate, please contact the Women's Health Research Unit confidential recruitment line at 503-494-3666, email whru@ohsu.edu, or visit https://www.ohsu.edu/womens-health/diagnosis-heavy-menstrual-bleeding-using-alternative-period-products
PI: Bethany Samuelson Bannow, MD; IRB:23668

12/02/2022

Do you or someone you know have endometriosis? If so, please check out the post below!

Our Women’s Health Research Unit is accepting new participants with endometriosis. An overview of endometriosis and our studies are as follows.

Endometriosis Overview
Endometriosis is a common condition in people who menstruate. It can cause significant pelvic and abdominal pain. It occurs when endometrial cells implant in area other than the lining of the uterus. Sometimes it lead to problems getting pregnant and sometimes it impacts people so much that they can't go to school or work on the days that experience pain. People with endometriosis can have pain with s*x, pain with urination and bowel movements, and other symptoms. For more information about endometriosis here is a good resource: ACOG: Endometriosis- https://www.acog.org/womens-health/faqs/endometriosis?utm_source=redirect&utm_

The Women's Health Research Unit is Currently seeking participants in two clinical trials looking at treatment for people with endometriosis. More information on each study is below.

• Endometriosis Related-Pain Study- This study is being done in order to investigate a novel investigational non-hormonal, injectable experimental drug which may relive moderate to severe endometriosis-associated pain. An experimental drug is one that is not approved by the United States Food and Drug Administration (FDA). The drug works by binding to, and blocking the function of prolactin receptors. Prolactin is a hormone that stimulates milk production after childbirth. This study is intended to find out if this new drug works and is safe for women with endometriosis-associated pain.

• Myovant SERENE Study- The drug we are studying is a GnRH receptor antagonist combined with estrogen and progesterone. In this study we want to learn if the investigational drug is a safe and effective option for pregnancy prevention specifically in women with uterine fibroids and endometriosis. If enrolled, you will receive the medication being tested in this study for one year. The study drug is taken by mouth once daily. You will not be allowed to use any other form of birth control for the duration of the study including condoms or withdrawal/”the pull-out method”.

If you have any questions and/or are interested in any of our studies, please contact the Women’s Health Research Unit’s confidential recruitment line at 503-494-3666 or email whru@ohsu.edu.

11/04/2022

New WHRU Study!

Taking a Life Course Perspective to Examine Critical Points of Intervention for Latinx Women Diagnosed with Cervical Cancer

Were you diagnosed with cervical cancer in the last 10 years?

We want to hear from you! If you are over the age of 45, were diagnosed with cervical cancer in the last 10 years, and identify as Latina. Then this study is for you!

Participation includes:

-A 1-3 hour interview. The interview can be done at your home, in a public setting, or online

-The interview will include questions about about your medications, treatment, diagnosis, challenges that you faced, and experiences with providers and/or family members. Among other questions. The purpose of this study is to better inform providers about the patient's experince and to lean about the areas in which more support can be provided.

To find out more information and to learn if you are qualified to participate, please contact the Women's Health Research Unit's confidential recruitment line at 503-494-3666 or email whru@ohsu.edu.

PI: Cirila Estela Vasquez Guzman
eIRB #: 23097

Nuevo Estudio!

Análisis de puntos fundamentales de intervención para mujeres latinas con diagnostico de cáncer de cuello de la matriz basado en la teoría del transcurso de la vida

¿Le diagnosticaron cáncer de cuello de la matriz en los últimos 10 años?

¡La invitamos a participar en nuestro estudio para mujeres Latinas que han sido diagnosticadas con cáncer de cuello uterino y tienen más de 45 años de edad! ¡Queremos que comparta su historia con nosotros!

Este estudio incluirá:

-Una entrevista de 1-3 hora(s) que se hará en su hogar, en un lugar público de confianza, o por línea

-La entrevista incluirá preguntas sobre sus medicamentos, tratamientos(s), diagnostico(s), desafíos que ha enfrentado, experiencias con proveedores de salud y familiares, entre otras preguntas. El propósito de esta entrevista es informar a los proveedores de salud, y aprender más sobre las áreas que podamos brindar apoyo para nuestras pacientes.

Para obtener más Information, comuníquese con Yareli Cornejo Torres al 503-494-3666 o envié un correo electrónico al whru@ohsu.edu.

10/28/2022

NEW STUDY- Endometriosis Pain Study

Interested in a new investigational medication to treat endometriosis pain?

The Women’s Health Research Unit is studying a novel non-hormonal, injectable investigational medication which may relieve endometriosis-related pain.

Qualifications to participate:
You may be eligible to participate if:
• Are premenopausal woman between ages 18-49
• Have a surgical diagnosis (laparotomy or laparoscopy) of
endometriosis within the last 10 years
• Are not pregnant or trying to get pregnant, or breastfeed &
willing to use nonhormonal birth control during the study
• Have not had hysterectomy and/or bilateral oophorectomy
• Do not have a history of osteoporosis

*There are additional qualification criteria*

To find out more information and to learn if you are qualified to participate, please contact the Women’s Health Research Unit’s confidential recruitment line at 503-494-3666, email whru@ohsu.edu, or visit our website www.ohsuwomenshealth.com/research.

Principal Investigator: Jeffrey Jensen MD, MPH
eIRB #: 24114

10/20/2022

We are hiring!

The Women’s Health Research Unit is seeking applicants for a Clinical Research Assistant (Coordinator). Spanish bilingual is preferred (not required).

To apply/for more information, please visit the following link-
https://externalcareers-ohsu.icims.com/jobs/19861/ti-clinical-research-assistant-2/job?hub=6&mobile=false&width=1252&height=500&bga=true&needsRedirect=false&jan1offset=-480&jun1offset=-420

If you have any questions, please email us at whru@ohsu.edu or call our research recruitment line at 503-494-3666.

10/07/2022

✨New Study Alert!✨

Investigational oral contraceptive pill for women with uterine fibroids or endometriosis.

OHSU is recruiting volunteers for a clinical trial to evaluate whether the investigational drug we are studying (a GnRH receptor antagonist combined with estrogen and progesterone) is a safe and effective option for pregnancy prevention specifically in women with uterine fibroids or endometriosis. If you qualify to participate, your total participation will last approximately 2 years and you will be asked to attend 8 doctor's visits and complete 4 follow up phone calls. You will also be asked to keep a daily electronic diary to record your drug intake of the investigational drug.

Qualified participants may be compensated up to $2,150.00 for time and travel costs associated with your participation in the trial.

To find out more information and to learn if you are qualified to participate, please contact the Women's Health Research Unit's confidential recruitment line to 503-494-3666, email whru@oshu.edu, or visit our website- https://www.ohsu.edu/womens-health/serene-study

PI: Jeffrey Jensen, MD,MPH

Myovant Serene Study CWH Webpage. The purpose of this study is to evaluate the safety and efficacy of an investigational contraceptive treatment in women with.

09/30/2022

Birth Control Ring Study

Help investigate a new birth control ring!

The Women’s Health Research Unit is studying an investigational vaginal contraception ring that may also help prevent HIV.

You may be eligible to participate if you:
• Are between ages 18 to 45
• Assigned female s*x at birth and not currently on female-to-male transition therapy
• Are protected from pregnancy by nonhormonal contraception, or not at risk for pregnancy (e.g. copper IUD, condoms, abstinence, sterilization, same-s*x partner)
• Are in good general health
• Have regular menstrual cycles (every 21-35 days)

To find out more information and to learn if you are qualified to participate, please contact the Women’s Health Research Unit’s confidential recruitment line at 503-494-3666, email whru@ohsu.edu, or visit our website www.ohsuwomenshealth.com/research.

IRB #23538;PI: Alison Edelman, MD, MPH

09/07/2022

****APPLICATION HAS BEEN CLOSED***

CAC-Last Call

Our Community Advisory Council application will be closing soon! If you are interested, please send your application to our Women's Health Research Unit (WHRU) (see instructions below).

CAC Overview
Our WHRU and Maternal Fetal Medicine Research Unit (MFMU) are happy to announce the creation of our Community Advisory Council (CAC). We are looking for former WHRU and/or MFMU participants,, community advocates, and community members! The CAC provides community feedback on our program and services and helps the research staff stay connected to the community that it serves.

If you are interested in health research and community advocacy, this is an opportunity for you!

To apply, DM us and/or contact us (see contact information below)

To learn more attend our information sessions or contact us (information below)
We also invite you to our virtual information session on:
• Wednesday, October 12th at 7:00PM or
• Thursday, October 13th at 12:00PM or
• We are also happy to schedule a time to meet one on one with you

Questions?
Contact us via email at whru@ohsu.edu or call our confidential line at 503-494-3666.